1 | 1709956-95-5 | 帕瑞考昔 | Parecoxib | C16H12ClNO3S
| | |
2 | 1037546-03-4 | Valdecoxib Impurity 9 | Valdecoxib Impurity 9 | C16H12ClNO3S
| | |
3 | 2304623-42-3 | 帕瑞考昔杂质56 | Valdecoxib Impurity 18 | C16H12ClNO3S
| | |
4 | 1022094-18-3 | 4-氯喹啉-8-基(1R,2S)-1-氨基-2-乙烯基环丙烷甲酸甲酯4-甲基苯磺酸盐 | 4-chloro-8-tosyloxyquinoline | C16H12ClNO3S
| | |
5 | 424789-76-4 | 1-Phenylsulfonyl-3-chloroacetylindole | 1-Phenylsulfonyl-3-chloroacetylindole | C16H12ClNO3S
| | |
6 | 1373038-57-3 | 3'-磺酰氯伐地考昔 | Valdecoxib 3'-Sulfonyl Chloride IMpurity | C16H12ClNO3S
| | |
7 | 1342646-77-8 | 8-(benzyloxy)quinoline-5-sulfonyl chloride | 8-(benzyloxy)quinoline-5-sulfonyl chloride | C16H12ClNO3S
| | |
8 | 139719-06-5 | 4-chloro-N-(4-hydroxy-1-naphthyl)benzenesulfonamide | 4-chloro-N-(4-hydroxy-1-naphthyl)benzenesulfonamide | C16H12ClNO3S
| | |
9 | 694472-86-1 | N-(3-chloro-4-hydroxyphenyl)-1-naphthalenesulfonamide | N-(3-chloro-4-hydroxyphenyl)-1-naphthalenesulfonamide | C16H12ClNO3S
| | |
10 | 343372-67-8 | 3-(2-CHLOROPHENYL)-5-[(PHENYLSULFONYL)METHYL]ISOXAZOLE | 3-(2-CHLOROPHENYL)-5-[(PHENYLSULFONYL)METHYL]ISOXAZOLE | C16H12ClNO3S
| | |
11 | | 2-(2-Hydroxybenzoyl)-3-(4-chlorophenyl)thiazolidin-4-one | 2-(2-Hydroxybenzoyl)-3-(4-chlorophenyl)thiazolidin-4-one | C16H12ClNO3S
| | |
12 | 861207-90-1 | 3-(3-CHLORO-4-METHOXYPHENYL)-2-(PHENYLSULFONYL)ACRYLONITRILE | 3-(3-CHLORO-4-METHOXYPHENYL)-2-(PHENYLSULFONYL)ACRYLONITRILE | C16H12ClNO3S
| | |
13 | 509074-26-4 | 4-(5-甲基-3-苯基-4-异恶唑基)苯磺酰氯 | Benzenesulfonyl chloride, 4-(5-methyl-3-phenyl-4-isoxazolyl)- | C16H12ClNO3S
| 标准品;医药中间体;杂质对照品;帕瑞昔布钠杂质;中间体-中间体;对照品-杂质对照品;帕瑞昔布钠相关中间体 | |
14 | | 2-((4-CHLOROPHENYL)SULFONYL)-3-(4-METHOXYPHENYL)PROP-2-ENENITRILE | 2-((4-CHLOROPHENYL)SULFONYL)-3-(4-METHOXYPHENYL)PROP-2-ENENITRILE | C16H12ClNO3S
| | |